ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Neuroimaging"

  • Abstract Number: 2256 • 2018 ACR/ARHP Annual Meeting

    Rheumatic Diseases Associated with Neuromyelitis Optica Spectrum Disorders (NMOSD): Prevalence, Clinical, Laboratory and Imaging Characteristics

    Milena Rodriguez Alvarez1, Su Zhaz Leon1, Fernando Cuascut2, Naureen Kabani3, Joshy Pathiparampil3, Kristaq Koci4, Manjeet Bhamra5, Latoya Freeman4, Alexandra Kreps6, Justin Levinson6, Sophia Francis6, Vinodkumar Velayndhan6, Steve Xie7, Abhimanyu Amarnani6, Helen Valsamis8, Yaacov Anziska6, Ellen M. Ginzler9 and Isabel M. McFarlane9, 1Rheumatology, SUNY Downstate, Brooklyn, NY, 2Neurology, SUNY Downstate, Brooklyn, NY, 3Internal Medicine, SUNY Downstate Medical Center, Brooklyn, NY, 4Medicine, SUNY Downstate Medical Center, Brooklyn, NY, 5Medicine, SUNY Downstate, Brooklyn, NY, 6SUNY Downstate, Brooklyn, NY, 7NYC Health + Hospitals Kings County, Brooklyn, NY, 8Neurology, NYC Health + Hospitals Kings County, Brooklyn, NY, 9Rheumatology, SUNY Downstate Medical Center, Brooklyn, NY

     Background/Purpose: NMOSD are autoimmune disorders characterized by optic neuritis (ON), longitudinal extensive transverse myelitis (LETM), and other clinical features. Aquaporin 4 antibodies (AQP4 Ab) have…
  • Abstract Number: 26 • 2017 Pediatric Rheumatology Symposium

    Gray Matter Volume Loss in Youth with SLE

    Andrea Knight1, Michelle Vickery2, Arastoo Vossough3, Guray Erus4, Jimit Doshi5 and Susan Furth6, 1Center for Pediatric Clinical Effectiveness & PolicyLab, Philadelphia, PA, 2PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, 3Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, 4Section on Biomedical Image Analysis, University of Pennsylvania, Philadelphia, PA, 5Section of Biomedical Image Analysis, University of Pennsylvania, Philadelphia, PA, 6Division of Nephrology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Neuropsychiatric SLE in children and adolescents presents diagnostic challenge due to limitations of conventional magnetic resonance imaging (MRI) to detect clinically relevant brain changes.…
  • Abstract Number: 2834 • 2016 ACR/ARHP Annual Meeting

    Utility of the Brain Perfusion Single Photon Emission Computed Tomography in Neuropsychiatric Manifestations of Systemic Lupus Erythematosus

    Jorge Medina-Rosas1, Murray Urowitz2, Jiandong Su3, Dafna D Gladman4 and Zahi Touma2, 1Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 4University of Toronto, Toronto, ON, Canada

    Background/Purpose:   The diagnosis of Neuropsychiatric Events (NPE) in SLE is challenging and it is mainly based on the physician judgment. Structural brain imaging has…
  • Abstract Number: 761 • 2015 ACR/ARHP Annual Meeting

    Neurometabolic Alterations in Korean Lupus Patients with Chronic Daily Headache

    Ji-Min Kim1, Tae-Han Lee1, Chang-Nam Son1, Sung Soo Kim2, Hyuk Won Chang3 and Sang-Hyon Kim1, 1Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Ulsan University School of Medicine, GangNeung Asan Hospital, Gangneung, South Korea, 3Department of Radiology, Keimyung University School of Medicine, Daegu, South Korea

    Background/Purpose: Neuropsychiatric systemic lupus erythematosus (SLE) includes a broad spectrum of neurologic and psychiatric manifestations. One of the most commonly observed neuopsychiatric symptoms is headache.…
  • Abstract Number: 3125 • 2015 ACR/ARHP Annual Meeting

    White Matter Magnetization Transfer Ratio Histogram Peak Height Helps Identifying Inflammatory Neuropsychiatric Systemic Lupus Erythematosus

    César Magro Checa1, Ece Ercan2, Bart J Emmer3, Ron Wolterbeek4, Itamar Ronen2, Mark A. Van Buchem2, T. W. J. Huizinga5 and Gerda M. Steup-Beekman5, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, C.J. Gorter Center for High Field MRI, Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Radiology, Erasmus Medical Center, Rotterdam, Netherlands, 4Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Magnetization transfer ratio (MTR) can be used to detect microstructural cerebral changes in normal-appearing brain tissue of neuropsychiatric systemic lupus erythematosus (NPSLE) patients. Our…
  • Abstract Number: 2146 • 2013 ACR/ARHP Annual Meeting

    Effects Of Chondroitin Sulfate On Brain Response To Painful Stimulation In Knee Osteoarthritis Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    Jordi Monfort1, Jesús Pujol2, O Contreras-Rodriguez2, Jone Llorente-Onaindia2, M López-Solà2, Laura Blanco-Hinojo2, J Deus2, H Ortiz2, Francisco Montañés3, M Campillo2, Pere Benito2, Laura Sánchez4, Marta Herrero5 and Josep Vergés6, 1Reumatologia, Hospital del Mar, Barcelona, Spain, 2Hospital del Mar, Barcelona, Spain, 3Rhaumatology, Hospital del Mar, Barcelona, Spain, 4Bioiberica, Barcelona, Spain, 5Pharmascience Division, Bioiberica S.A., Barcelona, Spain, 6Pre-Clinical R&D Area, Pharmascience Division, BIOIBERICA S.A., Barcelona, Spain

    Background/Purpose:  Knee osteoarthritis (OA) is a degenerative joint disease causing symptoms in 12% of people over the age of 65 . A variety of treatments…
  • Abstract Number: 1431 • 2012 ACR/ARHP Annual Meeting

    Single Photon Emission Computed Tomography Contributes to Clinical Assessments in Neuropsychiatric Systemic Lupus Erythematosus Patients

    Maasa Hama1, Mitsuhiro Takeno1, Atsushi Ihata1, Daiga Kishimoto1, Reikou Watanabe1, Takeaki Uehara2, Ryusuke Yoshimi1, Yukiko Asami1, Atsuhisa Ueda1 and Yoshiaki Ishigatsubo1, 1Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2Department of Rheumatology, Chigasaki Municipal Hospital, Chigasaki, Japan

    Background/Purpose: Because the clinical manifestations of NPSLE are diverse, multifaceted approaches are necessary to evaluate the disease activity and therapeutic responses. We investigated contribution of…
  • Abstract Number: 1397 • 2012 ACR/ARHP Annual Meeting

    Risk Factors Associated with Early Central Nervous System Damage Detected Through Perfusion MRI in Patients with Systemic Lupus Erythematosus

    Paola Tomietto1, Federica Casagrande2, Maja Ukmar2, Luca Weis2, Pia Morassi1, Rita Moretti3, Gianni Biolo3, Carlo Giansante3 and Maria Assunta Cova2, 1Internal Medicine Department, AOU Ospedali Riuniti di Trieste, Trieste, Italy, 2Radiology Department, Radiology Department, University of Trieste, Trieste, Italy, 3Internal Medicine Department, Internal Medicine Department, University of Trieste, Trieste, Italy

    Background/Purpose: Antiphospholipid antibodies (aPL), hypertension and accumulated damage (SLICC-DI)  have been associated to the severity of cerebral MRI lesions and to cognitive deficits in SLE.…
  • Abstract Number: 630 • 2012 ACR/ARHP Annual Meeting

    Risk Factors Associated with Early Central Nervous System Damage Detected Through Diffusion Tensor Imaging (DTI) in Patients with Systemic Lupus Erythematosus

    Paola Tomietto1, Federica Casagrande2, Maja Ukmar3, Luca Weis4, Pia Morassi5, Rita Moretti6, Gianni Biolo6, Carlo Giansante7 and Maria Assunta Cova8, 1Internal Medicine Department, AOU Ospedali Riuniti, Trieste, Italy, 2Radiology department, University of Trieste, Trieste, Italy, 3Radiology Department, University of Trieste, Trieste, 4Radiology Department, University of Trieste, Trieste, Italy, 5Internal Medicine Department, AOU Ospedali Riuniti di Trieste, Trieste, Italy, 6Internal Medicine Department, University of Trieste, Trieste, Italy, 7Internal Medicine epartment, University of Trieste, Trieste, Italy, 8Department of Radiology, University of Trieste, Trieste, Italy

    Background/Purpose: Antiphosholipid antibodies, SLICC-DI and some cardiovascular risk factors have been identified as risk factors for neuropsychiatric lupus (NPSLE). Diffusion tensor imaging (DTI) is an…
  • Abstract Number: 306 • 2012 ACR/ARHP Annual Meeting

    Children with Probable SLE by ACR Criteria May Need More Aggressive Lupus Treatment Early in the Disease Course

    Anjali Patwardhan1, Igor Dvorchik2 and Charles H. Spencer3, 1Pediatric Rheumatology, Nationwide Childrens Hospital, Columbus, OH, 2Biostatistics Division, Nationwide Children's Hospital,, Columbus, OH, 3Rheumatology, Nationwide Childrens Hospital, Columbus, OH

    Background/Purpose: This research explores whether delay of the childhood-onset SLE (cSLE) diagnosis until 4/11 ACR criteria are met affects patient outcome negatively Methods: Institutional Review…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology